Intestinal Diseases: all 952 studies
Page 10 of 10. Open to participants first (166), then studies with results posted, then the rest; newest registration first within each.
- Ulcerative Colitis Relapse Prevention Trial, HypnosisCompletedNCT00798642Not applicable
- Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's DiseaseWithdrawnNCT00783575
- Micro Ribonucleic Acid (RNA) as Cholinergic Tone and Inflammatory Regulator in Inflammatory Bowel DiseaseCompletedNCT00734331
- Thalidomide in Pediatric Inflammatory Bowel Diseases.CompletedNCT00720538Phase 3
- Managing Inflammatory Bowel DiseaseCompletedNCT00679003Not applicable
- Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and PsoriasisCompletedNCT00658827
- Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus OmeprazoleCompletedNCT00640809Phase 4
- Mucosal Gene Expression Defects in IBDCompletedNCT00639821
- Treatment of Mild Enteropathy Celiac DiseaseCompletedNCT00628823Not applicable
- Non-invasive Imaging of GI Inflammation Using Microbubble Contrast Enhanced UltrasonographyTerminatedNCT00591669Not applicable
- Value of Fecal CalprotectinCompletedNCT00577928
- Prevalence of Lymphoma in IBDCompletedNCT00577538
- Inflammatory Bowel Disease Research RegistryCompletedNCT00574028
- Phenotypic Characteristics of Inflammatory Bowel Disease in Southeast Asian Population - A Multi-centered US StudyWithdrawnNCT00573846
- Impact of Immunosuppression in IBD Patients on Response to Influenza VaccineCompletedNCT00542776
- Reducing Depressive Symptoms in Physically Ill YouthCompletedNCT00534911Not applicable
- Cost-effectiveness of TPMT PharmacogeneticsCompletedNCT00521950Not applicable
- Treatment of Depressed Adolescents With Physical IllnessCompletedNCT00446238Not applicable
- Surgical Decision Making Among People With Inflammatory Bowel DiseaseCompletedNCT00438711
- Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative ColitisCompletedNCT00408174Phase 3
- Safety and Efficacy of Using NaviAid™ BGE Device (Balloon Guided Endoscopy) For Endoscopic Diagnosis and TreatmentCompletedNCT00398203Not applicable
- Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/ Postoperative IleusCompletedNCT00388479Phase 3
- Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative IleusCompletedNCT00388401Phase 3
- Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative IleusCompletedNCT00388258Phase 3
- Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative IleusCompletedNCT00387309Phase 3
- Study Evaluating Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction (OIBD) in Subjects With Chronic Non-Malignant PainCompletedNCT00366431Phase 2
- Transition of Inflammatory Bowel Disease (IBD) Patients From Pediatric to Adult Gastroenterologist (GI)TerminatedNCT00360022Not applicable
- Telomere Repair Gene Mutation in Inflammatory Bowel DiseaseCompletedNCT00353639
- Genetic Studies of Inflammatory Bowel DiseaseCompletedNCT00340444
- Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With FistulasCompletedNCT00321412Phase 3
- Differences in Human Germinal Center B Cell Selection Revealed by Analysis of IgVH Gene Hypermutation and Lineage Trees in Inflammatory Bowel DiseaseStatus unknownNCT00291681
- Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer PainCompletedNCT00259922Phase 3
- Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer PainCompletedNCT00256932Phase 3
- Psychobiology in Inflammatory Bowel Disease(IBD)CompletedNCT00248742Not applicable
- Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer PainCompletedNCT00241722Phase 3
- MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by CytomegalovirusTerminatedNCT00237653Phase 3
- Infectious Agents in Pediatric Crohn'sCompletedNCT00237055
- Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety StudyCompletedNCT00232258Phase 2
- Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel DiseaseCompletedNCT00215020
- Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative IleusCompletedNCT00205842Phase 3
- Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD)TerminatedNCT00205062Phase 4
- The Influence of 5-Aminosalicylates on Thiopurine Metabolite LevelsCompletedNCT00167882Phase 4
- Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel DiseaseTerminatedNCT00152620Not applicable
- Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain SubjectsCompletedNCT00135577Phase 2
- Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain MedicationCompletedNCT00101998Phase 2
- Collection of Specimens for Study of Inflammatory Bowel DiseaseCompletedNCT00086554
- Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative ColitisCompletedNCT00073047Phase 2
- A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's DiseaseCompletedNCT00072943Phase 2
- A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel DiseaseCompletedNCT00035074Not applicable
- Treatment of Functional Bowel DisordersCompletedNCT00006157Phase 3
- Genetic Study of SitosterolemiaCompletedNCT00004481
- Parasitic Infections of the Gastrointestinal TractTerminatedNCT00001162